Merck & Co., Inc. (MRK) fell 1.76% on October 23, 2026, settling at $147.25 as selling pressure pushed shares lower in the session. Despite the daily decline, the stock carried a 1.35% gain over the trailing seven-day period, suggesting the single-day move did not fully erase recent momentum.
Over the past 30 days, however, MRK has declined 2.43%, reflecting a broader pullback from higher levels seen earlier in the month. The pharmaceutical giant's market capitalization stood at $369.78 billion at the close of trading.
The daily dip places Merck among a number of large-cap health-care names that saw pressure during the session. The stock's mixed short-term performance — a weekly gain alongside a monthly loss — points to choppy trading conditions in the shares over the recent period.
With a market capitalization near $370 billion, Merck remains one of the largest companies in the pharmaceutical sector. Investors will likely continue to monitor near-term price action to assess whether the 30-day slide stabilizes or extends further.
